| 
 Институт физиологически активных веществФедерального государственного бюджетного учреждения науки
 Федерального исследовательского центра проблем химической физики и медицинской химии
 Российской академии наук
Избранные публикации:2023
Bachurin, S. O.; Aksinenko, A. Y.; Makhaeva, G. F.; Shevtsova, E. F. Multipharmacophore strategy in medicinal chemistry for the design of drugs for the treatment of Alzheimer’s and some other neurodegenerative diseases. Russ Chem Bull  2023, 72, 130-147. DOI:10.1007/s11172-023-3718-01
Makhaeva, G. F.; Bachurin, S. O. Multifunctional Inhibitors of Cholinesterases for the Therapy of Alzheimer’s Disease (A Review).  Russ J Gen Chem 2023, 93, Suppl. 2, S1–S22. DOI:10.1134/S1070363223150161
Richardson, R. J.; Makhaeva, G. F. Organophosphorus compounds. In  Reference Module in Biomedical Sciences, Elsevier: 2023; pp 1-11. DOI:10.1016/b978-0-12-824315-2.00455-3
Nurieva, E. V.; Alekseev, A. A.; Zefirov, N. A.; Milaeva, E. R.; Kovaleva, N. V.; Proshin, A. N.; Makhaeva, G. F.; Zefirova, O. N. Annulated bicyclic isothioureas: identification of active and selective butyrylcholinesterase inhibitors. Mendeleev Commun  2023, 33, 77-79. DOI:10.1016/j.mencom.2023.01.024
Makhaeva, G. F.; Kovaleva, N. V.; Rudakova, E. V.; Boltneva, N. P.; Lushchekina, S. V.; Astakhova, T. Y.; Timokhina, E. N.; Serebryakova, O. G.; Shchepochkin, A. V.; Averkov, M. A.; Utepova, I. A.; Demina, N. S.; Radchenko, E. V.; Palyulin, V. A.; Fisenko, V. P.; Bachurin, S. O.; Chupakhin, O. N.; Charushin, V. N.; Richardson, R. J. Derivatives of 9-phosphorylated acridine as butyrylcholinesterase inhibitors with antioxidant activity and the ability to inhibit beta-amyloid self-aggregation: potential therapeutic agents for Alzheimer’s disease. Front Pharmacol  2023, 14, 1219980. DOI:10.3389/fphar.2023.1219980
Khudina, O. G.; Grishchenko, M. V.; Makhaeva, G. F.; Kovaleva, N. V.; Boltneva, N. P.; Rudakova, E. V.; Lushchekina, S. V.; Shchegolkov, E. V.; Borisevich, S. S.; Burgart, Y. V.; Saloutin, V. I.; Charushin, V. N. Conjugates of Amiridine and Thiouracil Derivatives as Effective Inhibitors of Butyrylcholinesterase with Potential to Block beta Amyloid Aggregation.  Arch Pharm  2023, e2300447. DOI:10.1002/ardp.202300447
Lapshina, M. A.; Shevtsova, E. F.; Grigoriev, V. V.; Aksinenko, A. Y.; Ustyugov, A. A.; Steinberg, D. A.; Maleev, G. V.; Dubrovskaya, E. S.; Goreva, T. V.; Epishina, T. A.; Zamoyski, V. L.; Makhaeva, G. F.; Fisenko, V. P.; Veselov, I. M.; Vinogradova, D. V.; Bachurin, S. O. New Adamantane-Containing Edaravone Conjugates as Potential Neuroprotective Agents for ALS Treatments. Molecules  2023, 28, 7567. DOI:10.3390/molecules28227567
Makhaeva G.F., Rudakova E.V., Kovaleva N.V., Boltneva N.P., Lushchekina S.V., Proshin A.N., Serkov I.V., Bachurin S.O. New highly efficient multifunctional cholinesterase inhibitors based on the conjugation of amiridine and tacrine homolog.  Russian Chemical Bulletin  2023, 72, 2738-2748
Makhaeva, G. F.; Kovaleva, N. V.; Rudakova, E. V.; Boltneva, N. P.; Grishchenko, M. V.; Lushchekina, S. V.; Astakhova, T. Y.; Serebryakova, O. G.; Timokhina, E. N.; Zhilina, E. F.; Shchegolkov, E. V.; Ulitko, M. V.; Radchenko, E. V.; Palyulin, V. A.; Burgart, Y. V.; Saloutin, V. I.; Bachurin, S. O.; Richardson, R. J. Conjugates of Tacrine and Salicylic Acid Derivatives as New Promising Multitarget Agents for Alzheimer's Disease. Int J Mol Sci  2023, 24, 2285. DOI:10.3390/ijms24032285
Burgart, Y. V.; Elkina, N. A.; Shchegolkov, E. V.; Krasnykh, O. P.; Makhaeva, G. F.; Triandafilova, G. A.; Solodnikov, S. Y.; Boltneva, N. P.; Rudakova, E. V.; Kovaleva, N. V.; Serebryakova, O. G.; Ulitko, M. V.; Borisevich, S. S.; Gerasimova, N. A.; Evstigneeva, N. P.; Kozlov, S. A.; Korolkova, Y. V.; Minin, A. S.; Belousova, A. V.; Mozhaitsev, E. S.; Klabukov, A. M.; Saloutin, V. I. Powerful Potential of Polyfluoroalkyl-Containing 4-Arylhydrazinylidenepyrazol-3-Ones for Pharmaceuticals. Molecules  2023, 28, 59. DOI:10.3390/molecules28010059
 2022Makhaeva, G. F.; Proshin, A. N.; Kovaleva, N. V.; Rudakova, E. V.; Boltneva, N. P.; Lushchekina, S. V.; Astakhova, T. Y.; Serkov, I. V.; Kalashnikova, I. P.; Bachurin, S. O. Synthesis and study of the biological activity of thiourea-containing amiridine derivatives as potential multi-target drugs for the treatment of Alzheimer’s disease. Russ Chem Bull  2022, 71, 2404-2415. DOI:10.1007/s11172-022-3668-y
Bachurin, S. O.; Shevtsova, E. F.; Makhaeva, G. F.; Aksinenko, A. Y.; Grigoriev, V. V.; Goreva, T. V.; Epishina, T. A.; Kovaleva, N. V.; Boltneva, N. P.; Lushchekina, S. V.; Rudakova, E. V.; Vinogradova, D. V.; Shevtsov, P. N.; Pushkareva, E. A.; Dubova, L. G.; Serkova, T. P.; Veselov, I. M.; Fisenko, V. P.; Richardson, R. J. Conjugates of Methylene Blue with Cycloalkaneindoles as New Multifunctional Agents for Potential Treatment of Neurodegenerative Disease. Int J Mol Sci  2022, 23. DOI:10.3390/ijms232213925
Burgart, Y. V.; Makhaeva, G. F.; Krasnykh, O. P.; Borisevich, S. S.; Agafonova, N. A.; Kovaleva, N. V.; Boltneva, N. P.; Rudakova, E. V.; Shchegolkov, E. V.; Triandafilova, G. A.; Gazizov, D. A.; Serebryakova, O. G.; Ulitko, M. V.; Khursan, S. L.; Saloutin, V. I.; Richardson, R. J. Synthesis of 4-Aminopyrazol-5-ols as Edaravone Analogs and Their Antioxidant Activity. Molecules  2022, 27, 7722. DOI:10.3390/molecules27227722 
Elkina, N. A.; Grishchenko, M. V.; Shchegolkov, E. V.; Makhaeva, G. F.; Kovaleva, N. V.; Rudakova, Е. V.; Boltneva, N. P.; Lushchekina, S. V.; Astakhova, T. Y.; Radchenko, E. V.; Palyulin, V. A.; Zhilina, E. F.; Perminova, A. N.; Lapshin, L. S.; Burgart, Y. V.; Saloutin, V. I.; Richardson, R. J. New Multifunctional Agents for Potential Alzheimer's Disease Treatment Based on Tacrine Conjugates With 2-Arylhydrazinylidene-1,3-Diketones. Biomolecules  2022, 12, 1551. DOI:10.3390/biom12111551
Grishchenko, M. V.; Makhaeva, G. F.; Burgart, Y. V.; Rudakova, E. V.; Boltneva, N. P.; Kovaleva, N. V.; Serebryakova, O. G.; Lushchekina, S. V.; Astakhova, T. Y.; Zhilina, E. F.; Shchegolkov, E. V.; Richardson, R. J.; Saloutin, V. I. Conjugates of Tacrine with Salicylamide as Promising Multitarget Agents for Alzheimer's Disease. ChemMedChem  2022, 17, e202200080. DOI:10.1002/cmdc.202200080
Grishchenko, M. V.; Elkina, N. A.; Makhaeva, G. F.; Burgart, Y. V.; Boltneva, N. P.; Rudakova, E. V.; Shchegolkov, E. V.; Kovaleva, N. V.; Serebryakova, O. G.; Saloutin, V. I. Conjugates of Tacrine with Aminomethylidene-Substituted Malonates: Synthesis and Biological Evaluation. Russ J Gen Chem  2022, 92, 2259-2266. DOI:10.1134/s1070363222110093
Makhaeva, G. F.; Kovaleva, N. V.; Boltneva, N. P.; Rudakova, E. V.; Lushchekina, S. V.; Astakhova, T. Y.; Serkov, I. V.; Proshin, A. N.; Radchenko, E. V.; Palyulin, V. A.; Korabecny, J.; Soukup, O.; Bachurin, S. O.; Richardson, R. J. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: N-Functionalization Determines the Multitarget Anti-Alzheimer's Activity Profile. Molecules  2022, 27, 1060. DOI:10.3390/molecules27031060
Shchegolkov, E. V.; Boltneva, N. P.; Burgart, Y. V.; Lushchekina, S. V.; Serebryakova, O. G.; Elkina, N. A.; Rudakova, E. V.; Perminova, A. N.; Makhaeva, G. F.; Saloutin, V. I. 3-(2-Arylhydrazono)-1,1,1-trifluro-3-(phenylsulfonyl)propan-2-ones as selective carboxylesterase inhibitors. Russ Chem Bull  2022, 71, 158-164. DOI:10.1007/s11172-022-3390-9
 2021Bachurin, S. O.; Makhaeva, G. F.; Shevtsova, E. F.; Aksinenko, A. Y.; Grigoriev, V. V.; Shevtsov, P. N.; Goreva, T. V.; Epishina, T. A.; Kovaleva, N. V.; Pushkareva, E. A.; Boltneva, N. P.; Lushchekina, S. V.; Gabrelyan, A. V.; Zamoyski, V. L.; Dubova, L. G.; Rudakova, E. V.; Fisenko, V. P.; Bovina, E. V.; Richardson, R. J. Conjugation of Aminoadamantane and ?-Carboline Pharmacophores Gives Rise to Unexpected Properties of Multifunctional Ligands. Molecules  2021, 26. DOI:10.3390/molecules26185527
Melentev, P. A.; Ryabova, E. V.; Surina, N. V.; Zhmujdina, D. R.; Komissarov, A. E.; Ivanova, E. A.; Boltneva, N. P.; Makhaeva, G. F.; Sliusarenko, M. I.; Yatsenko, A. S.; Mohylyak, I. I.; Matiytsiv, N. P.; Shcherbata, H. R.; Sarantseva, S. V. Loss of swiss cheese in Neurons Contributes to Neurodegeneration with Mitochondria Abnormalities, Reactive Oxygen Species Acceleration and Accumulation of Lipid Droplets in Drosophila Brain. Int J Mol Sci  2021, 22, 8275. DOI:10.3390/ijms22158275
Makhaeva, G. F.; Serkov, I. V.; Kovaleva, N. V.; Rudakova, E. V.; Boltneva, N. P.; Kochetkova, E. A.; Proshin, A. N.; Bachurin, S. O. Novel conjugates of 4-Amino-2,3-polymethylenequinolines and vanillin as potential multitarget agents for AD treatment. Mendeleev Commun  2021, 31, 606–608. DOI:10.1016/j.mencom.2021.09.005
Elkina, N. A.; Shchegolkov, E. V.; Burgart, Y. V.; Saloutin, V. I.; Boltneva, N. P.; Serebryakova, O. G.; Lushchekina, S. V.; Makhaeva, G. F. Synthesis of new efficient and selective carboxylesterase inhibitors based on adamantyl and citronellyl 4,4,4-trifluoro-2-arylhydrazonylidene-3-oxobutanoates. Russ Chem Bull  2021, 70, 567-572. DOI:10.1007/s11172-021-3126-2 
Makhaeva, G. F.; Lushchekina, S. V.; Boltneva, N. P.; Serebryakova, O. G.; Kovaleva, N. V.; Rudakova, E. V.; Elkina, N. A.; Shchegolkov, E. V.; Burgart, Y. V.; Stupina, T. S.; Terentiev, A. A.; Radchenko, E. V.; Palyulin, V. A.; Saloutin, V. I.; Bachurin, S. O.; Richardson, R. J. Novel Potent Bifunctional Carboxylesterase Inhibitors Based on a Polyfluoroalkyl-2-imino-1,3-dione Scaffold. Eur J Med Chem  2021, 217, 113385. DOI:10.1016/j.ejmech.2021.113385
Makhaeva, G. F.; Lushchekina, S. V.; Kovaleva, N. V.; Yu Astakhova, T.; Boltneva, N. P.; Rudakova, E. V.; Serebryakova, O. G.; Proshin, A. N.; Serkov, I. V.; Trofimova, T. P.; Tafeenko, V. A.; Radchenko, E. V.; Palyulin, V. A.; Fisenko, V. P.; Korabecny, J.; Soukup, O.; Richardson, R. J. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment. Bioorg Chem  2021, 112, 104974. DOI:10.1016/j.bioorg.2021.104974
 2020Richardson, R. J.; Fink, J. K.; Glynn, P.; Hufnagel, R. B.; Makhaeva, G. F.; Wijeyesakere, S. J. Neuropathy target esterase (NTE/PNPLA6) and organophosphorus compound-induced delayed neurotoxicity (OPIDN). Advances in Neurotoxicology  2020, 4, 1-78. DOI:10.1016/bs.ant.2020.01.001
Richardson, R. J.; Fink, J. K.; Worden, R. M.; Wijeyesakere, S. J.; Makhaeva, G. F. Neuropathy target esterase as a biomarker and biosensor of delayed neuropathic agents. In  Handbook of Toxicology of Chemical Warfare Agents,  3rd Ed.; R. Gupta Ed. Elsevier, San Diego: 2020; pp 1005-1025. 
Makhaeva, G. F.; Kovaleva, N. V.; Boltneva, N. P.; Lushchekina, S. V.; Rudakova, E. V.; Stupina, T. S.; Terentiev, A. A.; Serkov, I. V.; Proshin, A. N.; Radchenko, E. V.; Palyulin, V. A.; Bachurin, S. O.; Richardson, R. J. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation. Bioorg Chem  2020, 94, 103387. DOI:10.1016/j.bioorg.2019.103387
Makhaeva, G. F.; Shevtsova, E. F.; Aksinenko, A. Y.; Kovaleva, N. V.; Boltneva, N. P.; Lushchekina, S. V.; Rudakova, Е. V.; Pushkareva, E. A.; Serkova, T. P.; Dubova, L. G.; Shevtsov, P. N.; Sokolov, V. B.; Radchenko, E. V.; Palyulin, V. A.; Bachurin, S. O.; Richardson, R. J. Bis-gamma-carbolines as new potential multitarget agents for Alzheimer’s disease. Pure Appl Chem  2020, 92, 1057-1080. DOI:10.1515/pac-2019-1206
Makhaeva, G. F.; Kovaleva, N. V.; Rudakova, E. V.; Boltneva, N. P.; Lushchekina, S. V.; Faingold, I. I.; Poletaeva, D. A.; Soldatova, Y. V.; Kotelnikova, R. A.; Serkov, I. V.; Ustinov, A. K.; Proshin, A. N.; Radchenko, E. V.; Palyulin, V. A.; Richardson, R. J. New Multifunctional Agents Based on Conjugates of 4-Amino-2,3-polymethylenequinoline and Butylated Hydroxytoluene for Alzheimer’s Disease Treatment. Molecules  2020, 25, 5891. DOI:http://dx.doi.org/10.3390/molecules25245891
Makhaeva, G. F.; Kovaleva, N. V.; Boltneva, N. P.; Lushchekina, S. V.; Astakhova, T. Y.; Rudakova, E. V.; Proshin, A. N.; Serkov, I. V.; Radchenko, E. V.; Palyulin, V. A.; Bachurin, S. O.; Richardson, R. J. New Hybrids of 4-Amino-2,3-polymethylene-quinoline and p-Tolylsulfonamide as Dual Inhibitors of Acetyl- and Butyrylcholinesterase and Potential Multifunctional Agents for Alzheimer's Disease Treatment. Molecules  2020, 25, 25173915. DOI:10.3390/molecules25173915
Burgart, Y. V.; Agafonova, N. A.; Shchegolkov, E. V.; Krasnykh, O. P.; Kushch, S. O.; Evstigneeva, N. P.; Gerasimova, N. A.; Maslova, V. V.; Triandafilova, G. A.; Solodnikov, S. Y.; Ulitko, M. V.; Makhaeva, G. F.; Rudakova, E. V.; Borisevich, S. S.; Zilberberg, N. V.; Kungurov, N. V.; Saloutin, V. I.; Chupakhin, O. N. Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation. Eur J Med Chem  2020, 208, 112768. DOI:10.1016/j.ejmech.2020.112768
Akimov, M. G.; Kudryavtsev, D. S.; Kryukova, E. V.; Fomina-Ageeva, E. V.; Zakharov, S. S.; Gretskaya, N. M.; Zinchenko, G. N.; Serkov, I. V.; Makhaeva, G. F.; Boltneva, N. P.; Kovaleva, N. V.; Serebryakova, O. G.; Lushchekina, S. V.; Palikov, V. A.; Palikova, Y.; Dyachenko, I. A.; Kasheverov, I. E.; Tsetlin, V. I.; Bezuglov, V. V. Arachidonoylcholine and Other Unsaturated Long-Chain Acylcholines Are Endogenous Modulators of the Acetylcholine Signaling System. Biomolecules  2020, 10. DOI:10.3390/biom10020283
Makhaeva, G. F.; Kovaleva, N. V.; Boltneva, N. P.; Lushchekina, S. V.; Rudakova, E. V.; Stupina, T. S.; Terentiev, A. A.; Serkov, I. V.; Proshin, A. N.; Radchenko, E. V.; Palyulin, V. A.; Bachurin, S. O.; Richardson, R. J. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer’s disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation. Bioorg Chem  2020, 94, 103387 DOI:10.1016/j.bioorg.2019.103387
 2019Makhaeva, G. F.; Shevtsova, E. F.; Boltneva, N. P.; Lushchekina, S. V.; Kovaleva, N. V.; Rudakova, E. V.; Bachurin, S. O.; Richardson, R. J. Overview of novel multifunctional agents based on conjugates of gamma-carbolines, carbazoles, tetrahydrocarbazoles, phenothiazines, and aminoadamantanes for treatment of Alzheimer's disease. Chem Biol Interact  2019, 308, 224-234. DOI:10.1016/j.cbi.2019.05.020
Makhaeva, G. F.; Rudakova, E. V.; Kovaleva, N. V.; Lushchekina, S. V.; Boltneva, N. P.; Proshin, A. N.; Shchegolkov, E. V.; Burgart, Y. V.; Saloutin, V. I. Cholinesterase and carboxylesterase inhibitors as pharmacological agents. Russ Chem Bull  2019, 68, 967-984. DOI:10.1007/s11172-019-2507-2
Makhaeva, G. F.; Elkina, N. A.; Shchegolkov, E. V.; Boltneva, N. P.; Lushchekina, S. V.; Serebryakova, O. G.; Rudakova, E. V.; Kovaleva, N. V.; Radchenko, E. V.; Palyulin, V. V.; Burgart, Y. V.; Saloutin, V. I.; Bachurin, S. O.; Richardson, R. J. Synthesis, molecular docking, and biological evaluation of 3–oxo–2–tolylhydrazinylidene-4,4,4-trifluorobutanoates bearing higher and natural alcohol moieties as new selective carboxylesterase inhibitors. Bioorg Chem  2019, 91, 103097. DOI:10.1016/j.bioorg.2019.103097
Khudina, O.; Makhaeva, G.; Elkina, N. A.; Boltneva, N.; Serebryakova, O.; Shchegolkov, E.; Rudakova, E.; Lushchekina, S.; Burgart, Y.; Bachurin, S.; Richardson, R.; Saloutin, V. Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers. Bioorg Med Chem Lett  2019, 29, 126716. DOI:10.1016/j.bmcl.2019.126716
Bachurin, S. O.; Makhaeva, G. F.; Shevtsova, E. F.; Boltneva, N. P.; Kovaleva, N. V.; Lushchekina, S. V.; Rudakova, E. V.; Dubova, L. G.; Vinogradova, D. V.; Sokolov, V. B.; Aksinenko, A. Y.; Fisenko, V. P.; Richardson, R. J.; Aliev, G. Conjugates of methylene blue with gamma-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases. Sci Rep  2019, 9, 4873. DOI:10.1038/s41598-019-41272-4
 2018Lushchekina, S. V.; Makhaeva, G. F.; Novichkova, D. A.; Zueva, I. V.; Kovaleva, N. V.; Richardson, R. J. Supercomputer modeling of dual-site acetylcholinesterase (AChE) inhibition.  Supercomput Front Innov  2018, 5, 89-97. DOI:10.14529/jsfi1804
Makhaeva, G. F.; Boltneva, N. P.; Lushchekina, S. V.; Rudakova, E. V.; Serebryakova, O. G.; Kulikova, L. N.; Beloglazkin, A. A.; Borisov, R. S.; Richardson, R. J. Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics. Bioorg Med Chem  2018, 26, 4716-4725. DOI:10.1016/j.bmc.2018.08.010
Makhaeva, G. F.; Boltneva, N. P.; Kovaleva, N. V.; Rudakova, E. V.; Lushchekina, S. V.; Aksinenko, A. Y.; Sokolov, V. B. Influence of the gamma-carboline and carbazole pharmacophore moieties on anticholinesterase and antiradical activity of multifunctional agents for the treatment of neurodegenerative diseases. Russ Chem Bull  2018, 67, 1724-1731. DOI:10.1007/s11172-018-2282-5
Boltneva, N. P.; Makhaeva, G. F.; Shchegol’kov, E. V.; Burgart, Y. V.; Saloutin, V. I. Selective Carboxylesterase Inhibitors for Improving Efficacy, Safety and Rational use of Ester-Containing Drugs. Biomed Chem: Res Methods  2018, 1, e00026. DOI:10.18097/bmcrm00026
Makhaeva, G. F.; Rudakova, E. V.; Richardson, R. J. Investigation of the Esterase Status as a Complex Biomarker of Exposure to Organophosphorus Compounds. Biomed Chem: Res Methods  2018, 1, e00028. DOI:10.18097/bmcrm00028
Nechaeva, N.; Prokopkina, T.; Makhaeva, G.; Rudakova, E.; Boltneva, N.; Dishovsky, C.; Eremenko, A.; Kurochkin, I. Quantitative butyrylcholinesterase activity detection by surface-enhanced Raman spectroscopy. Sensors and Actuators B: Chemical  2018, 259, 75-82. DOI:10.1016/j.snb.2017.11.174
 2017Makhaeva, G. F.; Lushchekina, S. V.; Boltneva, N. P.; Serebryakova, O. G.; Rudakova, E. V.; Ustyugov, A. A.; Bachurin, S. O.; Shchepochkin, A. V.; Chupakhin, O. N.; Charushin, V. N.; Richardson, R. J. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.  Bioorg Med Chem  2017, 25, 5981-5994. DOI:10.1016/j.bmc.2017.09.028
Makhaeva, G. F.; Sokolov, V. B.; Shevtsova, E. F.; Kovaleva, N. V.; Lushchekina, S. V.; Boltneva, N. P.; Rudakova, E. V.; Aksinenko, A. Y.; Shevtsov, P. N.; Neganova, M. E.; Dubova, L. G.; Bachurin, S. O. Focused design of polypharmacophoric neuroprotective compounds: Conjugates of ?-carbolines with carbazole derivatives and tetrahydrocarbazole. Pure Appl Chem  2017, 89, 1167-1184. DOI:10.1515/pac-2017-0308
Shchegol'kov, E. V.; Makhaeva, G. F.; Boltneva, N. P.; Lushchekina, S. V.; Serebryakova, O. G.; Rudakova, E. V.; Kovaleva, N. V.; Burgart, Y. V.; Saloutin, V. I.; Chupakhin, O. N.; Bachurin, S. O.; Richardson, R. J. Synthesis, molecular docking, and biological activity of polyfluoroalkyl dihydroazolo[5,1-c][1,2,4]triazines as selective carboxylesterase inhibitors. Bioorg Med Chem  2017, 25, 3997-4007. DOI:10.1016/j.bmc.2017.05.045
Bachurin, S. O.; Shevtsova, E. F.; Makhaeva, G. F.; Grigoriev, V. V.; Boltneva, N. P.; Kovaleva, N. V.; Lushchekina, S. V.; Shevtsov, P. N.; Neganova, M. E.; Redkozubova, O. M.; Bovina, E. V.; Gabrelyan, A. V.; Fisenko, V. P.; Sokolov, V. B.; Aksinenko, A. Y.; Echeverria, V.; Barreto, G. E.; Aliev, G. Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment. Sci Rep  2017, 7, 45627. DOI:10.1038/srep45627
 2016Makhaeva, G. F.; Rudakova, E. V.; Serebryakova, O. G.; Aksinenko, A. Y.; Lushchekina, S. V.; Bachurin, S. O.; Richardson, R. J. Esterase profiles of organophosphorus compounds in vitro predict their behavior in vivo. Chem Biol Interact  2016, 259, 332-342. DOI:10.1016/j.cbi.2016.05.002
Makhaeva, G. F.; Rudakova, E. V.; Sigolaeva, L. V.; Kurochkin, I. N.; Richardson, R. J. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.  J Appl Toxicol  2016, 36, 1468-75. DOI:10.1002/jat.3305
Makhaeva, G. F.; Boltneva, N. P.; Lushchekina, S. V.; Serebryakova, O. G.; Stupina, T. S.; Terentiev, A. A.; Serkov, I. V.; Proshin, A. N.; Bachurin, S. O.; Richardson, R. J. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors. Bioorg Med Chem  2016, 24, 1050-1062. DOI:10.1016/j.bmc.2016.01.031
Varfolomeev, S. D.; Lushchekina, S. V.; Nemukhin, A. V.; Kulakova, A. M.; Kots, E. D.; Makhaeva, G. F.; Delacour, H.; Lockridge, O.; Masson, P. Molecular polymorphism of human enzymes as the basis of individual sensitivity to drugs. Supercomputer-assisted modeling as a tool for analysis of structural changes and enzymatic activity of proteins. Russ Chem Bull  2016, 65, 1592-1607. DOI:10.1007/s11172-016-1487-8
 2015 и ранееMakhaeva, G. F.; Lushchekina, S. V.; Boltneva, N. P.; Sokolov, V. B.; Grigoriev, V. V.; Serebryakova, O. G.; Vikhareva, E. A.; Aksinenko, A. Y.; Barreto, G. E.; Aliev, G.; Bachurin, S. O. Conjugates of g-carbolines and phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer disease. Sci Rep  2015, 5, 13164. DOI:10.1038/srep13164
Richardson, R. J.; Worden, R. M.; Wijeyesakere, S. J.; Hein, N. D.; Fink, J. K.; Makhaeva, G. F. Chapter 63 - Neuropathy Target Esterase as a Biomarker and Biosensor of Delayed Neuropathic Agents. In Handbook of Toxicology of Chemical Warfare Agents (Second Edition) , Gupta, R. C., Ed. Academic Press: Boston, 2015; pp 935-952. 
Makhaeva, G. F.; Rudakova, E. V.; Hein, N. D.; Serebryakova, O. G.; Kovaleva, N. V.; Boltneva, N. P.; Fink, J. K.; Richardson, R. J. Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds.  J Appl Toxicol  2014, n/a-n/a. DOI:10.1002/jat.2977
Makhaeva, G. F.; Radchenko, E. V.; Palyulin, V. A.; Rudakova, E. V.; Aksinenko, A. Y.; Sokolov, V. B.; Zefirov, N. S.; Richardson, R. J. Organophosphorus compound esterase profiles as predictors of therapeutic and toxic effects. Chem Biol Interact  2013, 203, 231-237. DOI:10.1016/j.cbi.2012.10.012
Richardson, R. J.; Hein, N. D.; Wijeyesakere, S. J.; Fink, J. K.; Makhaeva, G. F. Neuropathy target esterase (NTE): overview and future. Chem Biol Interact  2013, 203, 238-44. DOI:10.1016/j.cbi.2012.10.024
Rudakova, E. V.; Boltneva, N. P.; Makhaeva, G. F. Comparative analysis of esterase activities of human, mouse, and rat blood. Bull Exp Biol Med  2011, 152, 73-5. DOI:10.1007/s10517-011-1457-y
Sigolaeva, L.; Makhaeva, G.; Rudakova, E.; Boltneva, N.; Porus, M.; Dubacheva, G.; Eremenko, A.; Kurochkin, I.; Richardson, R. J. Biosensor analysis of blood esterases for organophosphorus compounds exposure assessment: approaches to simultaneous determination of several esterases. Chem Biol Interact 2010, 187, 312-7. DOI:10.1016/j.cbi.2010.01.028
Makhaeva, G. F.; Aksinenko, A. Y.; Sokolov, V. B.; Baskin, I. I.; Palyulin, V. A.; Zefirov, N. S.; Hein, N. D.; Kampf, J. W.; Wijeyesakere, S. J.; Richardson, R. J. Kinetics and mechanism of inhibition of serine esterases by fluorinated aminophosphonates. Chem Biol Interact  2010, 187, 177-184. DOI:10.1016/j.cbi.2009.12.018
Makhaeva, G.; Rudakova, E.; Boltneva, N.; Sigolaeva, L.; Eremenko, A.; Kurochkin, I.; Richardson, R. Blood Esterases as a Complex Biomarker for Exposure to Organophosphorus Compounds. In Counteraction to Chemical and Biological Terrorism in East European Countries, Dishovsky, C.; Pivovarov, A., Eds. Springer Netherlands: 2009; pp 177-194. 
Kurochkin, I. N.; Eremenko, A. V.; Makhaeva, G. F.; Sigolaeva, L. V.; Dubacheva, G. G.; Richardson, R. J. Multi-Strip Assay and Multimodal Biosensors for Environmental and Medical Monitoring of Neurotoxicants. In Counteraction to Chemical and Biological Terrorism in East European Countries, Dishovsky, C.; Pivovarov, A., Eds. Springer Netherlands: 2009; pp 219-229. 
Makhaeva, G. F.; Malygin, V. V.; Strakhova, N. N.; Sigolaeva, L. V.; Sokolovskaya, L. G.; Eremenko, A. V.; Kurochkin, I. N.; Richardson, R. J. Biosensor assay of neuropathy target esterase in whole blood as a new approach to OPIDN risk assessment: review of progress. Hum Exp Toxicol  2007, 26, 273-82. DOI:10.1177/0960327106070463
Sokolovskaya, L. G.; Sigolaeva, L. V.; Eremenko, A. V.; Gachok, I. V.; Makhaeva, G. F.; Strakhova, N. N.; Malygin, V. V.; Richardson, R. J.; Kurochkin, I. N. Improved electrochemical analysis of neuropathy target esterase activity by a tyrosinase carbon paste electrode modified by 1-methoxyphenazine methosulfate. Biotechnol Lett  2005, 27, 1211-8. DOI:10.1007/s10529-005-0020-1
Malygin, V. V.; Sokolov, V. B.; Richardson, R. J.; Makhaeva, G. F. Quantitative structure-activity relationships predict the delayed neurotoxicity potential of a series of O-alkyl-O-methylchloroformimino phenylphosphonates.  J Toxicol Environ Health  A 2003, 66, 611-25. DOI: 10.1080/15287390309353770
Makhaeva, G. F.; Sigolaeva, L. V.; Zhuravleva, L. V.; Eremenko, A. V.; Kurochkin, I. N.; Malygin, V. V.; Richardson, R. J. Biosensor detection of neuropathy target esterase in whole blood as a biomarker of exposure to neuropathic organophosphorus compounds J Toxicol Environ Health  A  2003, 66, 599-610. DOI:10.1080/15287390309353769
Sigolaeva, L. V.; Makower, A.; Eremenko, A. V.; Makhaeva, G. F.; Malygin, V. V.; Kurochkin, I. N.; Scheller, F. W. Bioelectrochemical analysis of neuropathy target esterase activity in blood. Anal Biochem  2001, 290, 1-9. DOI:10.1006/abio.2000.4822
 |